z-logo
Premium
Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve‐month follow‐up: Results of a three‐year national surveillance study
Author(s) -
Wong William
Publication year - 2007
Publication title -
journal of paediatrics and child health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.631
H-Index - 76
eISSN - 1440-1754
pISSN - 1034-4810
DOI - 10.1111/j.1440-1754.2007.01077.x
Subject(s) - medicine , nephrotic syndrome , incidence (geometry) , pediatrics , confidence interval , idiopathic nephrotic syndrome , proteinuria , kidney , physics , optics
Aim:  To describe the demographic, clinical features, steroid response, histopathology and complications of all children diagnosed with idiopathic nephrotic syndrome (INS) in New Zealand over a 3‐year period. Methods:  A questionnaire seeking relevant clinical information was sent to all paediatricians who reported a new case of nephrotic syndrome to the New Zealand Paediatric Surveillance Unit. A follow‐up questionnaire was sent to reporting paediatricians after the first 12 months of follow‐up. Results:  The incidence was 1.9 children per 100 000 under age 15 years. There was no significant difference in INS between ethnic groups. Approximately 80.4% were steroid responsive with median time to response of 8.4 days and mean time to relapse was 15.1 ± 12.1 weeks (10.1–19.8 95% confidence interval). Follow‐up at 12 months after diagnosis showed that two‐thirds were either steroid dependent or frequent relapsers. Steroid resistance patients had a more variable course with some developing chronic renal failure and other remaining persistently nephrotic. Conclusion:  The incidence and outcome of children with INS are similar to overseas studies. A large variety of steroid treatment regimens were noted. Current evidenced‐based guidelines to treat INS were used infrequently.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here